Skip to main content

UBS Group AG

Position in OCUL — Ocular Therapeutix, Inc

CIK 1610520 ZURICH, V8

Position in OCUL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$15,230,829
+$2,351,085 QoQ
Shares Held
1,551,001
+2.0% QoQ
Ownership
0.706%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 257 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 26% Shared 0% None 74%

Common Shares in OCUL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,271,661 across 562 Biotechnology names. OCUL ranks #93 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OCUL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,230,829 1,551,001
2026-03-31 $12,879,744 1,520,631
2025-12-31 $15,113,618 1,244,944
2025-09-30 $14,592,227 1,248,266
2025-06-30 $18,236,600 1,965,151
2025-03-31 $9,785,102 1,334,939
2024-12-31 $7,485,702 876,546
2024-09-30 $5,957,550 684,776
2024-06-30 $5,121,333 748,733
2024-03-31 $4,399,903 483,506
2023-12-31 $405,114 90,833
2023-09-30 $168,221 53,574
2023-06-30 $670,546 129,951
2023-03-31 $6,729 1,277
2022-12-31 $3,588 1,277
2022-09-30 $4,150 1,000
2022-06-30 $1,375,756 342,228
2022-03-31 $172,674 34,884
2021-12-31 $661,382 94,890
2021-09-30 $3,266,280 326,628
2021-06-30 $8,292,364 584,793
2021-03-31 $9,039,677 550,864
2020-12-31 $12,835,986 620,096
2020-09-30 $1,040,659 136,749
2020-06-30 $1,371,084 164,596
2020-03-31 $162,805 32,890